Related Experiment Video
Updated: May 28, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
The BioAssay network and its implications to future therapeutic discovery
Jintao Zhang1, Gerald H Lushington, Jun Huan
1Center for Bioinformatics, University of Kansas, Lawrence, KS 66045, USA.
BMC Bioinformatics
|October 13, 2011
Summary
This study uses network biology to analyze Molecular Libraries Initiative (MLI) data from PubChem. It prioritizes potential drug targets, showing value for chemical biology research and future drug discovery.
Area of Science:
- Chemical biology
- Network biology
- Drug discovery
Background:
- Drug discovery faces a decade-long bottleneck despite investment and technological advances.
- The National Institutes of Health (NIH) launched the Molecular Libraries Initiative (MLI) to expand potential drug targets and candidates.
- MLI data is publicly accessible via the PubChem web portal.
Purpose of the Study:
- To construct and analyze a bioassay network using MLI data.
- To integrate data from multiple biological databases for comprehensive analysis.
- To systematically evaluate the potential of bioassay targets as novel drug targets.
Main Methods:
- Constructed a network from PubChem bioassay data.
- Applied network biology concepts to characterize the bioassay network.
- Integrated data from DrugBank, OMIM, and UniHI; developed a model to prioritize target druggability.
Main Results:
- Characterized the bioassay network using network biology principles.
- Identified and prioritized potential new drug targets.
- Achieved approximately 70% accuracy in target prioritization based on literature evidence.
Conclusions:
- The MLI data serves as a valuable resource for chemical biology research.
- MLI data supports the discovery of future therapeutics.
- Network analysis provides a framework for evaluating drug target potential.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.